🇺🇸 Levothyroxine Pill in United States

8 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 23 April 2025 – 23 April 2026
• Total reports: 8

Most-reported reactions

1. Asthenia — 1 report (12.5%)
2. Back Pain — 1 report (12.5%)
3. Dysphagia — 1 report (12.5%)
4. Hospitalisation — 1 report (12.5%)
5. Neoplasm Malignant — 1 report (12.5%)
6. Pulmonary Embolism — 1 report (12.5%)
7. Respiratory Disorder — 1 report (12.5%)
8. Spinal Cord Compression — 1 report (12.5%)

Source database →

Frequently asked questions

Is Levothyroxine Pill approved in United States?

Levothyroxine Pill does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Levothyroxine Pill in United States?

Al-Kindy College of Medicine is the originator. The local marketing authorisation holder may differ — check the official source linked above.